These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23047168)

  • 1. Current status of HIV infection and ocular disease.
    Butler NJ; Thorne JE
    Curr Opin Ophthalmol; 2012 Nov; 23(6):517-22. PubMed ID: 23047168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment.
    Jabs DA; Van Natta ML; Holbrook JT; Kempen JH; Meinert CL; Davis MD;
    Ophthalmology; 2007 Apr; 114(4):787-93. PubMed ID: 17210182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ophthalmic manifestations of HIV in the highly active anti-retroviral therapy era.
    Mowatt L
    West Indian Med J; 2013; 62(4):305-12. PubMed ID: 24756590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment.
    Jabs DA; Van Natta ML; Holbrook JT; Kempen JH; Meinert CL; Davis MD;
    Ophthalmology; 2007 Apr; 114(4):780-6. PubMed ID: 17258320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uveitis as an initial manifestation of acquired immunodeficiency syndrome.
    Tsen CL; Chen SC; Chen YS; Sheu SJ
    Int J STD AIDS; 2017 Oct; 28(12):1224-1228. PubMed ID: 28201950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
    Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ophthalmic manifestations and risk factors for mortality of HIV patients in the post-highly active anti-retroviral therapy era.
    Lai TY; Wong RL; Luk FO; Chow VW; Chan CK; Lam DS
    Clin Exp Ophthalmol; 2011 Mar; 39(2):99-104. PubMed ID: 20796263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment.
    Jabs DA; Van Natta ML; Thorne JE; Weinberg DV; Meredith TA; Kuppermann BD; Sepkowitz K; Li HK;
    Ophthalmology; 2004 Dec; 111(12):2232-9. PubMed ID: 15582079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Sugar EA; Jabs DA; Ahuja A; Thorne JE; Danis RP; Meinert CL;
    Am J Ophthalmol; 2012 Jun; 153(6):1016-24.e5. PubMed ID: 22310076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
    Retina; 2000; 20(2):151-5. PubMed ID: 10783947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular Manifestations in Patients with Human Immunodeficiency Virus Infection in the Pre-HAART Versus the HAART Era in the North Indian Population.
    Agarwal A; Singh R; Sharma A; Gupta V; Dogra MR
    Ocul Immunol Inflamm; 2017 Jun; 25(3):396-404. PubMed ID: 26910292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular manifestations of HIV infection.
    Jabs DA
    Trans Am Ophthalmol Soc; 1995; 93():623-83. PubMed ID: 8719695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Examination of the posterior eye segment during HIV infection: what is new?].
    Guex-Crosier Y
    Klin Monbl Augenheilkd; 1999 May; 214(5):317-20. PubMed ID: 10420376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of Newly Diagnosed Cytomegalovirus Retinitis in a Developing Country in the HAART Era.
    Singh SR; Dogra M; Kaur S; Bajgai P; Tigari B; Handa S; Katoch D; Gupta V; Dogra MR; Sharma A; Singh R
    Ocul Immunol Inflamm; 2020; 28(1):119-125. PubMed ID: 30395753
    [No Abstract]   [Full Text] [Related]  

  • 15. [The role of HIV associated eye changes in the time of HAART (highly active antiretroviral therapy].
    Garweg JG; Barloggio A
    Ther Umsch; 2001 Jan; 58(1):21-7. PubMed ID: 11217483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seven years of HAART impact on ophthalmic management of HIV-infected patients.
    Kahraman G; Krepler K; Franz C; Ries E; Maar N; Wedrich A; Rieger A; Dejaco-Ruhswurm I
    Ocul Immunol Inflamm; 2005; 13(2-3):213-8. PubMed ID: 16019681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of ocular manifestations of HIV/AIDS in the highly active antiretroviral therapy (HAART) era: a different spectrum in Central South China.
    Luo J; Jing D; Kozak I; Huiming Z; Siying C; Yezhen Y; Xin Q; Luosheng T; Adelman RA; Forster SH
    Ophthalmic Epidemiol; 2013 Jun; 20(3):170-5. PubMed ID: 23713918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular association of HIV infection in the era of highly active antiretroviral therapy and the global perspective.
    Ng WT; Versace P
    Clin Exp Ophthalmol; 2005 Jun; 33(3):317-29. PubMed ID: 15932540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular manifestations of acquired immunodeficiency syndrome in Korea.
    Kim SJ; Park SJ; Yu HG; Kim NJ; Jang HC; Oh MD
    J Korean Med Sci; 2012 May; 27(5):542-6. PubMed ID: 22563221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus and intraocular inflammation in the era of highly active anti retroviral therapy - An update.
    Sudharshan S; Nair N; Curi A; Banker A; Kempen JH
    Indian J Ophthalmol; 2020 Sep; 68(9):1787-1798. PubMed ID: 32823395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.